Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Movsas

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
American Journal of Clinical Oncology|January 22, 2002
Metastatic meningioma to the lung with multiple pleural metastasesJ M Kaminski, B Movsas, E King, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2001
To move or not to move: measurements of prostate motion by urethrography using MRID Mah, G Freedman, B Movsas, et al.
Radiation Oncology Investigations|November 20, 1998
Response during radiotherapy may be associated with outcome in mediastinal Hodgkin's diseaseB Movsas, M C Barrows, S M Steinberg, et al.
Journal of Applied Clinical Medical Physics|March 2, 2005
Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRTL Wang, B Movsas, R Jacob, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directionsG E Hanks, A L Hanlon, T E Schultheiss, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 1998
Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06C B Scott, C Scarantino, R Urtasun, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1996
Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/MLG E Hanks, W R Lee, A L Hanlon, et al.
Urology|April 18, 2001
Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancerD Cvetkovic, B Movsas, A P Dicker, et al.
Cancer|November 7, 2000
Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) studyB Movsas, J D Chapman, R E Greenberg, et al.
American Journal of Clinical Oncology|October 5, 2001
Hypoxia in human prostate carcinoma: an Eppendorf PO2 studyB Movsas, J D Chapman, A L Hanlon, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
American Journal of Clinical Oncology|January 22, 2002
Metastatic meningioma to the lung with multiple pleural metastasesJ M Kaminski, B Movsas, E King, et al.
International Journal of Radiation Oncology, Biology, Physics|June 29, 2001
To move or not to move: measurements of prostate motion by urethrography using MRID Mah, G Freedman, B Movsas, et al.
Radiation Oncology Investigations|November 20, 1998
Response during radiotherapy may be associated with outcome in mediastinal Hodgkin's diseaseB Movsas, M C Barrows, S M Steinberg, et al.
Journal of Applied Clinical Medical Physics|March 2, 2005
Stereotactic IMRT for prostate cancer: dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRTL Wang, B Movsas, R Jacob, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directionsG E Hanks, A L Hanlon, T E Schultheiss, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 1998
Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06C B Scott, C Scarantino, R Urtasun, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 1996
Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/MLG E Hanks, W R Lee, A L Hanlon, et al.
Urology|April 18, 2001
Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancerD Cvetkovic, B Movsas, A P Dicker, et al.
Cancer|November 7, 2000
Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) studyB Movsas, J D Chapman, R E Greenberg, et al.
American Journal of Clinical Oncology|October 5, 2001
Hypoxia in human prostate carcinoma: an Eppendorf PO2 studyB Movsas, J D Chapman, A L Hanlon, et al.
Pageof 7